Prinston said the following irbesartan and irbesartan hydrochlorothiazide tablets have been recalled: • Irbesartan, 300 mg, 90 count, lot number 331B18009, expires February 2021 • Irbesartan ...

and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because of the potential presence of the N-nitrosoirbesartan impurity. "As part of Lupin's ...

All batches of Irbesartan tablets in 75 mg, 150 mg and 300 mg strengths and Irbesartan and Hydrochlorothiazide tablets in 150 mg/12.5 mg and 300 mg/12.5 mg strengths made by Lupin Pharmaceuticals ...

150 mg and 300 mg) and irbesartan/hydrochlorothiazide tablets (150 mg/12.5 mg and 300 mg/12.5 mg) in the U.S. Source: Adobe Stock N-nitrosoirbesartan impurity is a probable human carcinogen ...

Two types of blood pressure medication made by the company Lupin Pharmaceuticals are being recalled because they may contain high levels of a substance that could cause cancer. The Food and Drug ...

150 mg and 300 mg doses Irbesartan and Hydrochlorothiazide tablets in 150 mcg / 12.5 mcg doses Irbesartan and Hydrochlorothiazide tablets in 300 mcg / 12.5 mcg doses People who are currently ...

irbesartan 150 mg plus hydrochlorothiazide 12.5 mg and irbesartan 300 mg plus hydrochlorothiazide 12.5 mg). Use of this combination product should be reserved for patients who have not achieved ...

The study was conducted in adult patients aged 18 years or older with moderate hypertension that at enrolment was either untreated for at least 4 weeks or uncontrolled by monotherapy. Monotherapy ...

25 The price per year was €228 for irbesartan 150 mg/HCTZ 12.5 mg, €304 for irbesartan 300 mg/HCTZ 25 mg; €274 for losartan 50 mg/HCTZ 12.5 mg, €428 for losartan 100 mg/HCTZ ...